Clinical Trial

Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-20.
Trial Details
NCT Number NCT06946576
Lead Sponsor Oregon Health and Science University
Conditions Congenital Diaphragmatic Hernia
Enrollment 80 participants
Start Date 2025-09
Primary Completion 2030-04 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-02